Home » Clinical Outcomes

DURABLE RELIEF FOR YOUR NASAL AIRWAY OBSTRUCTION PATIENTS

VivAer® Stylus Clinical Evidence

The information on this site is intended for healthcare professionals only.
data design

Lasting Relief with VivAer Stylus

VivAer Stylus stands as the most extensively studied non-invasive solution for nasal airway obstruction (NAO), consistently delivering long-lasting, statistically significant relief. Clinical results, sustained for up to four years across multiple studies, highlight its effectiveness. Many patients have experienced easier breathing and have been able to reduce or even stop their medications following treatment.

Clinical Studies Demonstrate Long Lasting Results

Multiple studies have determined that VivAer Stylus is a well-tolerated procedure that reduces the symptoms of NAO. Patients experienced improvements across a broad set of quality of life (QoL) measures, including sleep, fatigue and overall well-being measurements. 1

See the 4-Year Pivotal Study Results

Improved NAO Symptoms by Treating the Septal Swell Body

Treating only the septal swell body (SSB) with VivAer Stylus has been shown to significantly and durably improve symptoms of NAO and enhance health-related quality of life (QOL) in patients suffering from nasal obstruction and congestion.2

Discover the SWELL Study

Improved Daytime Sleepiness

VivAer Stylus has been shown to significantly reduce daytime sleepiness in patients. Using the Epworth Sleepiness Scale (ESS), all patients experienced improved scores, including those with excessive daytime sleepiness. Post-treatment, ESS scores dropped by 5.8 points, bringing them below the threshold for normal daytime sleepiness, while patients with excessive daytime sleepiness saw an even greater improvement of 8.8 points. 3

Learn About the VATRAC RCT

The AERWAY long-term data showed that VivAer Stylus delivered relief to 90% of patients suffering from NAO. These results demonstrate that VivAer Stylus offers a useful option for otolaryngologists and patients, as the evidence showed statistically significant and sustained improvement even for patients with other untreated anatomical factors like septal deviation.

William Yao, M.D.
Department of Otorhinolaryngology – Head and Neck Surgery McGovern Medical School at UTHealth Houston Principal investigator of the AERWAY Study

WEB1322-34.A

Disclaimer

The VivAer® Stylus is indicated for use in otorhinolaryngology (ENT) surgery for the coagulation of soft tissue in the nasal airway, to treat nasal airway obstruction by shrinking submucosal tissue, including cartilage in the internal nasal valve area. Specific indications, contraindications, warnings, precautions, and safety information exist for these products. Aerin Medical relies on the physician to determine, assess and communicate to each patient all foreseeable risks of the procedure. A physician must always refer to the package insert, product label and/or instructions for use before using any of Aerin Medical’s products. Rx only. Current Procedural Terminology (CPT) Copyright 2025 American Medical Association (AMA). All rights reserved. CPT® is a registered trademark of the American Medical Association.

References:

The Reflective Total Nose Symptom Score (rTNSS) is a validated patient reported outcome used to describe symptoms of rhinitis. The assessment consists of 4 nasal symptom domains (runny nose [rhinorrhea], itchy nose, sneezing, and stuffiness [nasal congestion]). Each item is rated from 0 (absent) to 3 (severe). The 4 domains are added together to provide an overall score ranging from 0 to 12.

  1. Jacobowitz O, Ehmer D, Lanier B, Scurry W, Davis B. Long-term outcomes following repair of nasal valve collapse with temperature-controlled radiofrequency procedure for patients with nasal obstruction. Int Forum Allergy Rhinol. 2022;1-5.  https://doi.org/10.1002/alr.23019
  2. Pritikin, J., Silvers, S., Rosenbloom, J., Davis, B., Del Signore, A., Sedaghat, A.R., Tajudeen, B.A., Schmale, I. and Chandra, R.K. (2025), Twenty-Four-Month Outcomes Following Temperature-Controlled Radiofrequency Treatment for Septal Swell Body Hypertrophy: An Open-Label, Single-Arm Multicenter Study. Int Forum Allergy Rhinol.. https://doi.org/10.1002/alr.23541
  3. Han, J.K., Rosenthal, J.N., McDuffie, C.M., Yen, D.M., Bikhazi, N.B., Kakarlapudi, V.V. and Silvers, S.L. (2025), Temperature-Controlled Radiofrequency Treatment of the Nasal Valve in Patients With Nasal Obstruction: Long-Term Outcomes. Otolaryngol Head Neck Surg.https://doi.org/10.1002/ohn.1118